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The idea that sea-air has health promoting effects is nearly as old as human healthcare itself. Except for 
the increasing amount of epidemiological studies demonstrating a coastal proximity health effect, there 
is no physiological or other evidence for this. The biogenics hypothesis, which is investigated in this 
study, states that the natural marine products that are airborne via sea spray aerosolisation are the key 
health promoting substances in sea-air. According this theory, the PI3K/Akt/mTOR cell signaling pathway 
is the essential target. Airborne biogenic compounds can originate from a variety of marine sources. 
Within this project, it was postulated that marine algae are the main producers of marine bioactive 
compounds which aerosolise in the form of sea spray. 
In the current project, the effects of biogenic compounds on human lung tissue were examined, using in 
vitro experiments. Hence, the effects of three types of (mixtures of) biogenic molecules were examined 
on a lung cell line and compared against a negative control treatment. In addition, a known 
pharmaceutical inhibitor of the mTOR pathway (mTOR inhibitor) was included to identify the molecular 
response associated with this inhibition. Each treatment consisted of four replicates. After 43h of 
exposure, cells were harvested for mRNA extraction Afterwards, RNA concentration and quality were 
verified. Sequence libraries of single 75 basepair reads were then prepared from each RNA sample and 
subsequently sequenced on the Illumina NextSeq 500. After sequencing, the data were subjected to 
quality analysis and subsequently mapped to a human reference genome. For each sample, count data 
per gene was generated. The count data was statistically analysed with the EdgeR package in the R 
statistical computing environment after data filtering and data normalization. Different treatments were 
compared using an exact test for pairwise comparison to identify differentially expressed genes. In this 
way the effects on the mTOR cell signaling pathway could be determined at a molecular level and other 
potentially involved pathways could be identified. 
Significant molecular responses were observed that distinguished each of the treatments from each other 
and from the negative control, clearly indicating that all treatments caused effects at the molecular level. 
Overall, the data from this experiment allows to state that: (1) a specific gene, which is frequently 
suggested as a new pharmaceutical target, is a key gene influenced in this study, (2) marine biogenic 
products can indeed regulate the mTOR pathway, (3) the responsible biogenic substances not only 
influence mTOR but a whole subset of signaling pathways and molecules involved in detoxification and 
(anti-)cancer. 
Finally, it can be concluded that these results are in line with our previous results and that this study is 
an essential step towards the confirmation of the biogenics hypothesis. 
